Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.
Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development.
Novel Approaches Towards a Functional Cure of HIV/AIDS.
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).